or Try an Advanced Search...

    Technical Analysis for VERA - Vera Therapeutics, Inc.

    Grade Last Price % Change Price Change
    C 36.29 0.30% 0.11
    VERA closed up 0.3 percent on Monday, July 1, 2024, on 59 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Up Down Up
    Historical VERA trend table...
    Date Alert Name Type % Chg
    20 DMA Resistance Bearish 0.00%
    Shooting Star Candlestick Bearish 0.00%
    Lizard Bearish Bearish Day Trade Setup 0.00%
    MACD Bullish Signal Line Cross Bullish 0.00%
    Doji - Bearish? Reversal 0.00%
    Up 3 Days in a Row Strength 0.00%
    Slingshot Bearish Bearish Swing Setup 0.30%
    Pocket Pivot Bullish Swing Setup 0.30%
    Gapped Up Strength 0.30%
    Oversold Stochastic Weakness 0.30%
    Older End-of-Day Signals for VERA ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 10 hours ago
    20 DMA Resistance about 10 hours ago
    Up 3% about 10 hours ago
    Up 2% about 10 hours ago
    Up 1% about 10 hours ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Analyze My Stocks!
    Configure default chart indicators
    VERA Chart by TradingView
    Basic chart:

    Profile

    Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with immunoglobulin A nephropathy. The company was formerly known as Trucode Gene Repair, Inc. and changed its name to Vera Therapeutics, Inc. in April 2020. Vera Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biotechnology Life Sciences Health Care

    Is VERA a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 1 bullish, 1 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jul 1 Vera Therapeutics appoints David Johnson as COO
    Jun 11 Vera Therapeutics Appoints Christy J. Oliger to Board of Directors
    Jun 7 Vera Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
    May 31 Wall Street Snaps Five-Week Winning Streak, Economic Growth Slows, Inflation Holds Steady In April: This Week In The Market
    May 29 Nvidia Is Up 186% From A Year Ago, Yet These 7 Stocks Have More Than Doubled Their Returns Over The AI Chipmaker
    May 28 Vera gains FDA Breakthrough Therapy Designation for atacicept
    May 28 Vera Therapeutics Receives U.S. FDA Breakthrough Therapy Designation for Atacicept in Immunoglobulin A Nephropathy (IgAN)
    May 25 Vera Therapeutics Presents 72-week eGFR Stabilization and Rapid Hematuria Improvement in Phase 2b ORIGIN Study of Atacicept in IgAN at the 61st European Renal Association Congress
    May 9 Vera Therapeutics GAAP EPS of -$0.56
    May 9 Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
    See more VERA news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 50.78
    52 Week Low 9.24
    Average Volume 809,746
    200-Day Moving Average 28.47
    50-Day Moving Average 39.08
    20-Day Moving Average 37.00
    10-Day Moving Average 35.38
    Average True Range 2.10
    RSI (14) 45.95
    ADX 14.72
    +DI 19.60
    -DI 20.05
    Chandelier Exit (Long, 3 ATRs) 35.75
    Chandelier Exit (Short, 3 ATRs) 38.94
    Upper Bollinger Bands 40.94
    Lower Bollinger Band 33.07
    Percent B (%b) 0.41
    BandWidth 21.28
    MACD Line -1.16
    MACD Signal Line -1.22
    MACD Histogram 0.057
    Fundamentals Value
    Market Cap 1.95 Billion
    Num Shares 53.7 Million
    EPS -2.86
    Price-to-Earnings (P/E) Ratio -12.69
    Price-to-Sales 0.00
    Price-to-Book 16.31
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 38.78
    Resistance 3 (R3) 39.00 38.38 38.37
    Resistance 2 (R2) 38.38 37.75 38.28 38.23
    Resistance 1 (R1) 37.34 37.36 37.86 37.12 38.09
    Pivot Point 36.72 36.72 36.99 36.62 36.72
    Support 1 (S1) 35.68 36.09 36.20 35.46 34.49
    Support 2 (S2) 35.06 35.70 34.96 34.35
    Support 3 (S3) 34.02 35.06 34.22
    Support 4 (S4) 33.80